VOICED : Merck pide en EEUU autorización para una píldora contra el covid-19

Merck has requested emergency approval in the U.S. for Molnupiravir, a COVID-19 antiviral pill. Clinical trials showed it reduced hospitalization and death rates compared to a placebo. The drug works by reducing the virus's ability to reproduce, effective against all variants. Experts caution it is not a cure and should complement vaccines. Merck aims to produce 10 million treatments by the end of 2021.

What new insight or understanding did you gain from this video?